Pfizer Inc.
Tissue factor pathway inhibitor antibodies and uses thereof

Last updated:

Abstract:

The invention relates to antibodies, and antigen-binding fragments thereof, that specifically bind TFPI and inhibit an activity thereof. Such antibodies and fragments are useful for treating bleeding disorders and shortening clotting time.

Status:
Grant
Type:

Utility

Filling date:

17 Aug 2016

Issue date:

4 Feb 2020